Bioecologic control of the gastrointestinal tract: The role of flora and supplemented probiotics and synbiotics

Gastroenterology Clinics of North America

Volumn 34, Issue 3, 2005, Pages 413-436

  Bengmark, Stig ^a,b,c  

^a ROYAL FREE AND UNIVERSITY COLLEGE MEDICAL SCHOOL   (United Kingdom)

^b LUND UNIVERSITY   (Sweden)

^c NONE   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

INFLIXIMAB; OMEGA 3 FATTY ACID; PREBIOTIC AGENT; PROBIOTIC AGENT; YOGHURT;

ANTIOXIDANT ACTIVITY; BACTERIAL FLORA; BACTERIAL OVERGROWTH; BACTERIAL STRAIN; CLOSTRIDIUM DIFFICILE; COLON BIOPSY; COLON FLORA; CROHN DISEASE; DIARRHEA; DIET SUPPLEMENTATION; DIETARY INTAKE; ESCHERICHIA COLI; HELICOBACTER INFECTION; HELICOBACTER PYLORI; HIGH FIBER DIET; ILEITIS; INTESTINE FLORA; INTESTINE MUCOSA; IRRITABLE COLON; ISCHEMIC COLITIS; LACTOBACILLUS PLANTARUM; LIVER DISEASE; LIVER TRANSPLANTATION; NONHUMAN; PREOPERATIVE TREATMENT; REVIEW; SYMBIOSIS; ULCERATIVE COLITIS; VITAMIN SUPPLEMENTATION;

EID: 23244457596     PISSN: 08898553     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.gtc.2005.05.002     Document Type: Review

References (127)

1. S. Bengmark Acute and "chronic" phase response - a mother of disease Clin Nutr 23 2004 1256 1266
2. 2 production in immune cells in autoimmune-prone NZBxNZW F1 mice Br J Nutr 75 1996 711 722
3. S. Watanabe, K. Onozaki, S. Yamamoto, and H. Okuyama Regulation by dietary essential fatty acid balance of tumor necrosis factor production in mouse macrophages J Leukoc Biol 53 1993 151 156
4. K. Roszkowski, K.L. Ko, and J. Beuth Intestinal microflora of BALB/c-mice and function of local immune cells Zeitschrift für Bakteriologie und Hygien 270 1988 270 279
5. G. Pulverer, J. Beuth, and W. Roszkowski Bacteria of human physiological microflora liberate immunomodulating peptides Zentralbl Bakteriol 272 1990 467 476
6. T.B. Larsen, J.N. Nielsen, and L. Fredholm Platelets and anticoagulant capacity in patients with inflammatory bowel disease Pathophysiol Haemost Thromb 32 2002 92 96
7. L.T. Bjerregaard, N.J. Nederby, and L. Fredholm Hyperhomocysteinaemia, coagulation pathway activation and thrombophilia in patients with inflammatory bowel disease Scand J Gastroenterol 37 2002 62 67
8. E. Capristo, G. Mingrone, G. Addolorato, A.V. Greco, and G. Gasbarrini Glucose metabolism and insulin sensitivity in inactive inflammatory bowel disease Aliment Pharmacol Ther 13 1999 209 217
9. J.O. Hunter Dietary studies P.R. Gibson D.P. Jewell Topics in gastroenterology 1985 Blackwell Science Oxford (UK) 305 313
10. M.D. Holmes, M.N. Pollak, W.C. Willett, and S.E. Hankinson Dietary correlates of plasma insulin-like growth factor I and insulinlike growth factor binding protein 3 concentrations Cancer Epidemiol Biomarkers Prev 11 2002 852 861
11. J. Braly, and M.A. Hoggan Dangerous grains 2002 Penguin Putnam Inc New York: Avery
12. K.D. Fine, K. Do, and K. Schulte High prevalence pf celiac sprue-like HLA-DQ genes and enteropathy in patients with microscopic colitis syndrome Am J Gastroenterol 95 2000 1974 1982
13. R. Di Cagno, M. De Angelis, S. Auricchio, L. Greco, C. Clarke, and M. De Vincenzi Sourdough bread made from wheat and nontoxic flours and started with selected lactobacilli is tolerated in celiac sprue patients Appl Environ Microbiol 70 2004 1088 1096
14. S. Bengmark Prospect for a new and rediscovered form of therapy: probiotic and phage P.W. Andrew P. Oystron G.L. Smith D.E. Stewart-Tull Fighting infection in the 21st century 2000 Blackwell Scientific Oxford (UK) 97 132
15. B. Gustafsson The future of germ-free research 1985 Liss New York: Alan R
16. L.V. Hooper, T. Midtvedt, and J.I. Gordon How host-microbial interactions shape the nutrient environment of the mammalian intestine Annu Rev Nutr 22 2002 283
17. J.C. Alverdy, R.S. Laughlin, and R. Wu Influence of the critically ill state on host pathogen interactions within the intestine: gut derived sepsis redefined Crit Care Med 31 2003 598 607
18. P. Leveau, X. Wang, V. Soltesz, I. Ihse, and R. Andersson Alterations in intestinal permeability and microflora in experimental acute pancreatitis Int J Pancreat 20 1996 119 125
19. R. Andersson, X. Wang, I. Ihse, P. Leveau, and I. Ihse The influence of abdominal sepsis on acute pancreatitis in rats: a study on mortality, permeability, arterial blood pressure and intestinal blood flow Pancreas 11 1995 365 373
20. Knight DJW, Ala'Aldeen D, Bengmark S, Girling KJ. The effect of synbiotics on gastrointestinal flora in the critically ill [abstract]. Br J Anaesth Abstract 2004;92:307-8.
21. A.A. Lencner, C.P. Lencner, and M.E. Mikelsaar Die quantitative Zusammensetzung der Lactoflora des Verdauungstrakts vor und nach kosmischen Flügen unterschiedlicher Dauer Nahrung 28 1984 607 613
22. E. Sepp, K. Julge, M. Vasur, P. Naaber, B. Bjorksten, and M. Mikelsaar Intestinal microflora of Estonian and Swedish infants Acta Pediatr 86 1997 956 961
23. I. Adlerberth, B. Carlsson, and P. deMan Intestinal colonization with Enterobacteriaceae in Parkistani and Swedish hospital-delivered infants Acta Pediatr Scand 80 1991 602 610
24. S.M. Finegold, V.L. Sutter, and G.E. Mathisen Normal indigenous intestinal flora D.J. Hentges Human intestinal microflora in health and disease 1983 Academic Press London 3 31
25. S. Ahrné, S. Nobaek, B. Jeppsson, I. Adlerberth, A.E. Wold, and G. Molin The normal Lactobacillus flora in healthy human rectal and oral mucosa J Appl Microbiol 85 1998 88 94
26. B. Lorber Are all diseases infectious? Ann Intern Med 125 1996 844 851
27. R. Fabia, A. Ar'Rajab, and M.L. Johansson Impairment of bacterial flora in human ulcerative colitis and in experimental colitis in the rat Digestion 54 1993 248 255
28. S.J. Ott, D.F. Wenderoth, and J. Hampe Reduction in diversity of the colonic mucosa associated bacterial microflora in patients with active inflammatory bowel disease Gut 53 2004 685 693
29. A. Swidsinski, A. Ladhoff, and A. Pernthaler Mucosal flora in inflammatory bowel disease Gastroenterology 122 2002 44 54
30. A. Darfeuille-Michaud, J. Boudeau, and P. Bulois High prevalence of adherent-invasive Escherichia coli associated with ileal mucosa in Crohn's disease Gastroenterology 127 2004 412 421
31. M.D. Grisham Oxidants and free radicals in inflammatory bowel disease Lancet 344 1994 859 861
32. V. Gross, H. Arndt, T. Andus, K.D. Palitzsch, and J. Scholmerich Free radicals in inflammatory bowel diseases: pathophysiology and therapeutic implications Hepatogastroenterology 41 1994 320 327
33. B. Sido, V. Hack, A. Hochlehnert, H. Lipps, C. Herfarth, and W. Dröge Impairment of intestinal glutathione synthesis in patients with inflammatory bowel disease Gut 42 1998 485 492
34. O. Miralles-Barrachina, G. Savoye, and L. Belmonte-Zalar Low levels of glutathione in endoscopic biopsies in patients with Crohn's colitis: the role of malnutrition Clin Nutr 18 1999 313 317
35. E.J. Park, C.H. Jeon, G. Ko, J. Kim, and D.H. Sohn Protective effects of curcumin in rat liver injury induced by carbon tetrachloride J Pharm Pharmacol 52 2000 437 440
36. A.A. Nanji, K. Jokelainen, G.L. Tipoe, A. Rahemtulla, P. Thomas, and A.J. Dannenberg Curcumin prevents alcohol-induced liver disease in rats by inhibiting the expression of KF-κB-dependent genes Am J Physiol Gastroenterol Liver Physiol 284 2003 G321 G327
37. B. Sahl, V. Assi, and V. Templeman Curcumin attenuates DBN-induced colitis Am J Physiol Gastroenterol Liver Physiol 285 2003 G235 G243
38. A. Ukil, S. Maity, S. Karmakar, N. Datta, J.R. Vedasiromoni, and P.K. Das Curcumin, the major component of food flavour turmeric, reduces mucosal injury in trinitrobenzene sulphonic acid-induced colitis B J Pharmacol 139 2003 209 218
39. F. Fernadez-Banares, J. Hinojosa, and J.L. Sanchez-Lombrana Randomized clinical trial of Plantago ovata seeds (dietary fiber) as compared with mesalamine in maintaining remission in ulcerative colitis Am J Gastroenterol 94 1999 427 433
40. O. Kanauchi, T. Iwanaga, and K. Mitsuyama Germinated barley foodstuff feeding: a novel neutraceutical strategy for ulcerative colitis Digestion 63 Suppl 1 2001 S60 S67
41. P.E. Wischmeyer, J. Riehm, and K.D. Singleton Glutamine attenuates tumor necrosis factor-α release and enhances heat shock protein 72 in human peripheral blood mononuclear cells Nutrition 19 2003 1 6
42. C. Hallert, I. Björck, M. Nyman, A. Pousette, C. Granno, and H. Svensson Increasing fecal butyrate in ulcerative colitis patients by diet: controlled pilot study Inflamm Bowel Dis 9 2003 116 121
43. C.F.M. Welters, E. Heineman, F.B.J.M. Thunnissen, A.E.J.M. van den Bogaard, P.B. Soeters, and C.G.M.I. Baeten Effect of dietary inulin supplementation on inflammation of pouch mucosa in patients with an ileal pouch-anal anastomosis Dis Colon Rectum 45 2002 621 627
44. M.J. Hopkins, and G.T. Macfarlane Nondigestible oligosaccharides enhance bacterial colonization resistance against Clostridium difficile in vitro Appl Environ Microbiol 69 2003 1920 1927
45. S. Dasarathy Role of gut bacteria in the therapy of hepatic encephalopathy with lactulose and antibiotics Indian J Gastroenterol 22 Suppl 2 2003 S50 S53
46. G.H. Rabbani, T. Teka, and S.K. Saha Clinical studies in persistent diarrhea: dietary management with green banana or pectin in Bangladesh children Gastroenterology 121 2001 554 560
47. Q. Liu, Z.P. Duan, K. Ha da, S. Bengmark, J. Kurtovic, and S.M. Riordan Synbiotic modulation of gut flora: effect on minimal hepatic encephalopathy in patients with cirrhosis Hepatology 39 2004 1441 1449
48. A.Y. Tamine, V.M.E. Marshall, and R.K. Robinson Microbiological and technical aspects of milks fermented by bifidobacteria J Dairy Res 62 1995 151 187
49. Y. Deguchi, T. Morishita, and M. Mutai Comparative studies on synthesis of water-soluble vitamins among human species of bifidobacteria J Agric Biol Chem 49 1985 13 19
50. Y. Tamii, N. Yoshimitsu, Y. Watanabe, Y. Kuwabara, and S. Nagai Effects of milk fermented by culturing with various lactic acid bacteria and a yeast on serum cholesterol level in rats J Ferment Bioeng 81 1996 181 182
51. A.M.P. Gomes, and F.K. Malcata Bifidobacterium spp. and Lactobacillus acidophilus: biological, biochemical, technological and therapeutical properties relevant for use as probiotics Trends Food Sci Tehnol 10 1999 139 157
52. C.E. McNaught, N.P. Woodcock, J. MacFie, and C.J. Mitchell A prospective randomized study of the probiotic Lactobacillus plantarum 299V on indices of gut barrier function in elective surgical patients Gut 51 2002 827 831
53. M. Miettinen, M. Alander, and A. von Wright The survival of and cytokine induction by lactic acid bacteria after passage through a gastrointestinal model Microb Ecol Health Dis 10 1998 41 47
54. P.K. Jain, C.E. McNaught, A.D.G. Anderson, J. MacFie, and C.J. Mitchell Influence of synbiotic containing Lactobacillus acidophilus LA5, Bifidobacterium lactis BP 12, Streptococcus thermophilus, Lactobacillus bulgaricus and oligofructose on gut barrier function and sepsis in critically ill patients: a randomized controlled trial Clin Nutr 23 2004 467 475
55. N.P. Woodcock, C.E. McNaught, D.R. Morgan, K.L. Gregg, and J. MacFie An investigation into the effect of a probiotic on gut immune function in surgical patients Clin Nutr 23 2004 1069 1073
56. S. Bengmark Synbiotics to strengthen gut barrier function and reduce morbidity in critically ill patients Clin Nutr 23 2004 441 445
57. M. Müller, and D. Lier Fermentation of fructans by epiphytic lactic acid bacteria J Appl Bacteriol 76 1994 406 411
58. P. Naaber, I. Smidt, J. Stsepetova, T. Brilene, H. Annuk, and M. Mikelsaar Inhibition of Clostridium difficile strains by intestinal Lactobacillus species Med Microbiol 53 2004 551 554
59. M. Moss Moss, and D.L. Freed Survival trends, coronary event rates, and the MONICA project: monitoring trends and determinants in cardiovascular disease Lancet 354 1999 862 864
60. L.-Q. Qin, P.-Y. Wang, K. Kaneko, and A. Sato Estrogen: one of the risk factors in milk for prostate cancer Med Hypoth 62 2004 133-42
61. J.L. Outwater, A. Nicholson, and N. Barnard Dairy products and breast cancer: the IGF-1, estrogen and bGH hypothesis Med Hypoth 48 1997 453 461
62. N.W. Solomons Nature's perfect food revisited: recent insights on milk consumption and chronic disease risk Nutr Rev 60 2002 180 182
63. M.J. Gnoth, C. Kunz, E. Kinne-Saffran, and S. Rudloff Human milk oligosacharides are minimally digested in vitro J Nutr 130 2000 3014 3020
64. M. Kalliomaki, S. Salminen, and H. Arvilommi Probiotics in primary prevention of atopic disease: a randomized placebo-controlled trial Lancet 357 2001 1076 1079
65. T. Jalonen Identical intestinal permeability changes in children with different clinical manifestations of cow's milk allergy J Allergy Clin Immunol 88 1991 737 742
66. E. Isolauri, H. Majamaa, T. Arvola, I. Rantala, E. Virtanen, and H. Arvilommi Lactobacillus casei strain GG reverses increased intestinal permeability induced by cow milk in suckling rats Gastroenterology 105 1993 1643 1650
67. U. Bengtsson, T.W. Knutson, L. Knutson, A. Dannaeus, R. Hallgren, and S. Ahlstedt Increased levels of hyaluronan and albumin after intestinal challenge in adult patients with cow's milk intolerance Clin Exp Allergy 26 1996 96 103
68. U. Bengtsson, T.W. Knutson, L. Knutson, A. Dannaeus, R. Hallgren, and S. Ahlstedt Eosinophil cationic protein and histamine after intestinal challenge in patients with cow's milk intolerance Allerg Clin Immunol 100 1997 216 221
69. B.M. Ehn, B. Ekstrand, U. Bengtsson, and S. Ahlstedt Modification of IgE binding during heat processing of the cow's milk allergen J Agric Food Chem 52 2004 1398 1403
70. P.E. Kankanpää, S.J. Salminen, E. Isolauri, and Y.K. Lee The influence of polyunsaturated fatty acids on probiotic growth and adhesion FEMS Microbiol Lett 194 2001 149 153
71. S. Cruchet, M.C. Obregon, G. Salazar, E. Diaz, and M. Gotteland Effect of the ingestion of a dietary product containing Lactobacillus johnsonii La1 on Helicobacter pylori colonization in children Nutrition 19 2003 716 721
72. M.L. Johansson, G. Molin, B. Jeppsson, S. Nobaek, S. Ahrne, and S. Bengmark Administration of different lactobacillus strains in fermented oatmeal soup: in vivo colonization of human intestinal mucosa and effect on the indigenous flora Appl Environ Microbiol 59 1993 15 20
73. Kruszewska K, Lan J, Lorca G, Yanagisawa N, Marklinder I, Ljungh Å. Selection of lactic acid bacteria as probiotic strains by in vitro tests. Proceedings of the XVI International Congress on Microbial Ecology and Disease, Noordwijkerhout, The Netherlands, October 2001. Microecology and Therapy 2002;29:37-51.
74. Å. Ljungh, J.-G. Lan, and N. Yamagisawa Isolation, selection and characteristics of Lactobacillus paracasei ssp paracasei isolate F19 Microb Ecol Health Dis 3 Suppl 2002 4 6
75. T.J. Borodo, E.F. Warren, S. Leis, R. Surace, and O. Ashman Treatment of ulcerative colitis using fecal bacteriotherapy J Clin Gastroenterol 37 2003 42 47
76. T.J. Borody, E.F. Warren, S.M. Leis, R. Surace, O. Ashman, and S. Siarakas Bacteriotherapy using fecal flora: toying with human motions J Clin Gastroenterol 38 2004 475 483
77. S.J. Allan, B. Okoko, E. Martinez, G. Gregorio, and L.F. Dans Probiotics for treating infectious diarrhoea The Cochrane Database of Systematic Reviews issue 4 2003 Art No CD003048 pub2, DOI:10.1002/14651858.CD003048.pub2
78. G.W. Elmer, L.V. McFarland, C.M. Surawics, L. Danko, L. Surawics Danko, and R.N. Greenberg Behavior of Sacharomyces boulardii in recurrent Clostridium difficile disease patients Aliment Pharmacol Ther 13 1999 1663 1668
79. M.R. Thomas, S.C. Litin, D.R. Osmon, A.P. Corr, A.L. Weaver, and C.M. Lohse Lack of effect of lactobacillus GG on antibiotic-associated diarrhea: a randomized placebo-controlled trial Mayo Clin Proc 76 2001 883 889
80. M. Wullt, M.L. Johansson-Hagslätt, and I. Odenholt Lactobacillus plantarum 299v for the treatment of recurrent Clostridium difficile-associated diarrhoea: a double blind, placebo-controlled trial Scand J Infect Dis 35 2003 365 367
81. K. Plein, and J. Hotz Therapeutic effects of Saccharomyces boulardii on mild residual symptoms in a stable phase of Crohn's disease with special respect to chronic diarrhea - a pilot study Z Gastroenterol 31 1993 129 134
82. M. Guslandi, G. Mezzi, M. Sorghi, and P.A. Testoni Saccharomyces boulardi in maintenance treatment of Crohn's disease Dig Dis Sci 45 2000 1462 1464
83. H.A. Malchow Crohn's disease and Escherichia coli: a new approach in therapy to maintain remission in colonic Crohn's disease? J Clin Gastroenterol 25 1997 653 658
84. C. Prantera, M.L. Scribano, G. Falasco, A. Andreoli, and C. Luzi Ineffectiveness of probiotics in preventing recurrence after curative resection of Crohn's disease: a randomised controlled trial with Lactobacillus GG Gut 51 2002 405 409
85. M. Schultz, A. Timmer, H.H. Herfarth, R.B. Sartor, J.A. Vanderhoof, and H.C. Rath Lactobacillus GG in inducing and maintaining remission of Crohn's disease BMC Gastroenterol 4 2004 1 4
86. M. Campieri, F. Rizzello, and A. Venturi Combination of antibiotic and probiotic treatment is efficacious in prophylaxis of post-operative recurrence of Crohn's disease: a randomized controlled study vs mesalamine [abstract] Gastroenterology 118 2000 A4279
87. Rutgeerts P, D'Haens G, Baert F, et al. Randomized placebo controlled trial of pro- and prebiotics (synbiotics cocktail) for maintenance of infliximab induced remission of luminal Crohn's disease (CD). Digestive Week USA, May 2004. Gastroenterology 2004; 126:A467.
88. W. Kruiz, E. Schutz, P. Fric, B. Fixa, G. Judmaier, and M. Stolte Double-blind comparison of an oral Escherichia coli preparation and meselazine in maintaining remission of ulcerative colitis Aliment Pharmacol Ther 11 1997 853 858
89. B.J. Rembacken, A.M. Snelling, P.M. Hawkey, D.M. Chalmers, and A.T. Axon Non-pathogenic Escherichia coli versus mesalazine for the treatment of ulcerative colitis: a randomised trial Lancet 354 1999 635 639
90. W. Kruiz, P. Fric, and M. Stolte Maintenance of remission in ulcerative colitis is equally effective with Escherichia coli Nissle 1997 and with standard mesalamine Gastroenterology 120 2001 A139
91. W.A. Faubion, and W.J. Sandborn Probiotic therapy with E coli for ulcerative colitis: take the good with the bad Gastroenterology 118 2000 650 655
92. A. Venturi, P. Gionchetti, and F. Rizzello Impact on the composition of the faecal flora by a new probiotic preparation: preliminary data on maintenance treatment of patients with ulcerative colitis Aliment Pharmacol Ther 13 1999 1103 1108
93. Pathmakanthan S, Walsh M, Bengmark S, Willemse PJA, Bardhan KD. Efficacy and tolerability treating acute distal ulcerative colitis with synbiotic enemas: a pilot trial. Gut 2002;51(Suppl 1):A307.
94. J. Kuisma, S. Mentula, H. Jarvinen, A. Kahri, M. Saxelin, and M. Farkkila Effect of Lactobacillus rhamnosus GG on ileal pouch inflammation and microbial flora Aliment Pharmacol Ther 17 2001 509 515
95. M.P. Gosselink, W.R. Schouten, L.M.C. van Lieshout, W.C.J. Hop, J.D. Laman, and J.G.H. Ruseler-van Embden Delay of first onset of pouchitis by oral intake of the probiotic strain Lactobacillus rhamnosus GG Dis Colon Rectum 47 2004 876 884
96. P. Gionchetti, F. Rizzello, and A. Venturi Oral bacteriotherapy as maintenance treatment in patients with chronic pouchitis: a double-blind, placebo-controlled trial Gastroenterology 119 2000 305 309
97. T. Mimura, U. Helwig, and G. Paggioli One daily high dose probiotic therapy (VSL#3) for maintaining remission in recurrent or refractory pouchitis Gut 53 2004 108 114
98. P. Gionchett, F. Rizzello, and U. Helwig Prophylaxis of pouchitis onset with probiotic therapy: a double-bland, placebo-controlled trial Gastroenterology 124 2003 1202 1209
99. B.G. Stanghellini, R. De Giorgio, and C. Cremon Activated mast cells in proximity to colonic nerves correlate with abdominal pain in irritable bowel syndrome Gastroenterology 126 2004 693 702
100. A. Uribe, M. Alam, O. Johansson, T. Midtvedt, and E. Theodorsson Microflora modulates endocrine cells in gastrointestinal mucosa of the rat Gastroenterology 107 1994 1259 1269
101. M.A. O'Sullivan, and C.A. O'Morain Bacterial supplementation in the irritable bowel syndrome: a randomised double-blind crossover study Dig Liver Dis 32 2000 294 301
102. O'Mahony L, McCarthy J, Kelly P, et al. Lactobacillus and Bifidobacterium in irritable bowel syndrome (IBS): symptom responses and relationship to cytokine profiles. Gastroenterology 2005;128:541-51.
103. A. Saggioro Probiotics in the treatment of irritable bowel syndrome J Clin Gastroenterol 38 suppl 2 2004 S104 S106
104. H.J. Kim, M. Camilleri, and S. McKinzie A randomized controlled trial of a probiotic, VSL#3, on gut transit and symptoms in diarrhoea-predominant irritable bowel syndrome Aliment Pharmacol Ther 17 2003 895 904
105. K. Niedzielin, H. Kordecki, and B. Birkenfeld A controlled, double-blind, randomised study on the efficacy of Lactobacillus plantarum 299 in patients with irritable bowel syndrome Eur J Gastroenterol Hepatol 13 2001 1143 1147
106. S. Nobaek, M.-L. Johansson, G. Molin, S. Ahrne, and B. Jeppsson Alteration of intestinal microflora is associated with reduction in abdominal bloating and pain in patients with irritable syndrome Am J Gastroenterol 95 2000 1231 1238
107. S. Sen, M.M. Mullan, T.J. Parker, J.T. Woolner, S.A. Tarry, and J.O. Hunter Effect of Lactobacillus plantarum 299v on colonic fermentation and symptoms of irritable bowel syndrome Dig Dis Sci 47 2002 2615 2620
108. P. Marteau, M. Minekus, R. Havenaar, and J.H. Huis in't Veld Survival of lactic acid bacteria in a dynamic model of the stomach and small intestine: validation and the effects of bile J Dairy Sci 80 1997 1031 1037
109. G.L. Lorca, T. Wadström, G. Fond de Valdez, and Å. Ljungh Lactobacillus acidophilus autolysins inhibit Helicobacter pylori in vitro Curr Microbiol 42 2001 39 44
110. F. Canducci, A. Armuzzi, and F. Cremonini A lyophilised and inactivated culture of Lactobacillus acidophilus increases Helicobacter pylori eradication rates Aliment Pharmacol Ther 14 2000 1625 1629
111. A. Armuzzi, F. Cremonini, and V. Ojetti Effect of Lactobacillus GG supplementation on antibiotic-associated gastrointestinal side effects during Helicobacter pylori eradication therapy: a pilot study Digestion 63 2001 1 7
112. A. Armuzzi, F. Cremonini, and F. Bartolozzi The effect of oral administration of Lactobacillus GG on associated gastrointestinal side effects during Helicobacter eradication Aliment Pharmacol Ther 15 2001 163 169
113. P. Michetti, G. Dorta, and P.H. Wiesel Effect of whey based culture supernatant of Lactobacillus acidophilus (jonsonii) La1 on Helicobacter pylori infections in humans Digestion 60 1999 203 209
114. C.P. Felley, I. Corthesy-Theulaz, and J.L. Rivero Favourable effects of an acidified milk (La-1) on Helicobacter pylori gastritis in man Eur J Gastroenterol Hepatol 13 2001 25 29
115. F. Cremonini, S. Di Caro, and M. Covino Effect of different probiotic preparations on anti-Helicobacter pylori therapy-related side effects: a parallel group, triple blind, placebo-controlled study Am J Gastroenterol 97 2002 2744 2749
116. K.Y. Wang, S.N. Li, and C.S. Liu Effects of ingesting Lactobacillus- and Bifidobacterium-containing yogurt in subjects with colonized Helicobacter pylori Am J Clin Nutr 80 2004 737 741
117. S.M. Riordan, N. Skinner, and A. Nagree Peripheral blood mononuclear cell expression of toll-like receptors and relation to cytokine levels in cirrhosis Hepatology 37 2003 1154 1164
118. J. Kurtovic, U. Ruettimann, H. Adamson, S. Bengmark, R. Williams, and S.M. Riordan Improvement in indocyanine green clearance following synbiotic treatment in cirrhosis Gut 52 Suppl 2003 A3
119. N. Rayes, S. Hansen, and D. Seehofer Early enteral supply of Lactobacillus and fibre vs selective bowel decontamination (SBD) - a controlled trial in liver transplant recipients Transplantation 74 2002 123 127
120. Rayes N, Seehofer D, Theruvath T, et al. Combined perioperative enteral supply of bioactive pre- and probiotics abolishes postoperative bacterial infections in human liver transplantation - a randomised, double blind clinical trial. Am J Transplant 2005;5:125-30.
121. N. Rayes, S. Hansen, and K. Boucsein Early enteral supply of fibre and lactobacilli vs parenteral nutrition - a controlled trial in major abdominal surgery patients Nutrition 18 2002 609 615
122. F. Shanahan Probiotics and inflammatory bowel disease: from fads and fantasy to facts and future Br J Nutr 88 suppl 2002 S5 S9
123. R.B. Sartor Therapeutic manipulations of the enteric microflora in inflammatory bowel diseases: antibiotics, probiotics and prebiotics Gastroenterology 126 2004 1620 1633
124. L.R. Sutherland, and S. Hanauer Schmolmerich J, and the Taskforce on Clinical Trials of the International Organisation for the Study of Inflammatory Bowel Disease. Standards for trials of therapy in inflammatory bowel disease Inflamm Bowel Dis 3 1997 277 283
125. S.J.O. Veldhuyzen van Zanten, N.J. Talley, P. Bytzer, K.B. Klein, P.J. Whorwell, and A.R. Zinsmeister Design of treatment trials for functional gastrointestinal disorders Gut 45 suppl 2 1999 1169 1177
126. E. Metchnikoff The prolongation of life: optimistic studies 1907 William Heinemann London
127. B. Eiseman, W. Silen, G.S. Bascom, and A.J. Kauvar Fecal enema as an adjunct in the treatment of pseudomembranous enterocolitis Surgery 44 1958 854 859